Literature DB >> 6386579

Increased vasopressor responsiveness to angiotensin II in type 1 (insulin-dependent) diabetic patients without complications.

P L Drury, G M Smith, J B Ferriss.   

Abstract

The blood pressure response to infused angiotensin II (0.3 to 3 ng X kg-1 X min-1) was investigated in six normotensive patients with Type 1 (insulin-dependent) diabetes free of complications and in six healthy subjects matched for age, sex and weight. Basal blood pressures (111/68 and 114/72 mmHg) and basal plasma angiotensin II levels (18.0 +/- 5.2 and 14.1 +/- 2.4 pmol/l; mean + SD) were similar in the diabetic and control groups as were 24 h urinary excretions of sodium (157 +/- 88 and 154 +/- 84 mmol/24 h). Equal increments in plasma angiotensin II were produced during the infusions in the two groups. Increases in both diastolic and systolic blood pressure were significantly greater in the diabetic patients throughout the infusion. Mean diastolic increments were: 6.7 versus 1.3 mmHg (0.3 ng dose), 11.0 versus 6.9 mmHg (1 ng dose) and 16.7 versus 12.3 mmHg (3 ng dose) (p less than 0.001). Corresponding figures for systolic pressure were: 8.7 versus 1.3 mmHg, 10.3 versus 3.7 mmHg and 15.3 versus 8.7 mmHg (p less than 0.001). Vasopressor responsiveness to angiotensin II is thus increased in Type 1 diabetic patients without complications; it may, therefore, be a consequence of the diabetes rather than of the presence of microvascular disease or hypertension.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386579     DOI: 10.1007/bf00273801

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  25 in total

1.  Abnormal albumin excretion after two provocative renal tests in diabetes: physical exercise and lysine injection.

Authors:  C E Mogensen; E Vittinghus; K Sølling
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

2.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

3.  Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects.

Authors:  A R Christlieb; H U Janka; B Kraus; R E Gleason; E A Icasas-Cabral; L M Aiello; B V Cabral; A Solano
Journal:  Diabetes       Date:  1976-04       Impact factor: 9.461

4.  Factors in the control of plasma renin activity and concentration in Type 1 (insulin-dependent) diabetes.

Authors:  P L Drury; H J Bodansky; C J Oddie; C R Edwards
Journal:  Clin Endocrinol (Oxf)       Date:  1984-05       Impact factor: 3.478

5.  Relationship between impaired parasympathetic and sympathetic cardiovascular control in diabetes mellitus.

Authors:  W Wieling; C Borst; M A van Dongen Torman; J W van der Hofstede; J F van Brederode; E Endert; A J Dunning
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

6.  Plasma angiotensin II and the control of diabetes mellitus.

Authors:  P A Sullivan; H Gonggrijp; M J Crowley; J B Ferriss; D J O'Sullivan
Journal:  Clin Endocrinol (Oxf)       Date:  1980-10       Impact factor: 3.478

Review 7.  Diabetes and arterial hypertension.

Authors:  P L Drury
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

8.  Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years.

Authors:  T Dornan; J I Mann; R Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-16

9.  Total plasma clearance of infused norepinephrine in non-azotemic diabetes mellitus.

Authors:  C Beretta-Piccoli; P Weidmann
Journal:  Klin Wochenschr       Date:  1982-06-01

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  12 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  [Nephropathy and hypertension in type II diabetes].

Authors:  E Ritz; K Bergis; K Strojek; C Keller
Journal:  Med Klin (Munich)       Date:  1997-07-15

Review 3.  Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes.

Authors:  P Hamet; N Kalant; S A Ross; T W Wilson; F H Leenen; R B Haynes
Journal:  CMAJ       Date:  1988-12-01       Impact factor: 8.262

Review 4.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

5.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

Review 6.  Effects of antihypertensive therapy on kidney function in diabetic patients.

Authors:  B Scherstén
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  The effect of insulin on the vascular reactivity of isolated resistance arteries taken from healthy volunteers.

Authors:  P G McNally; I G Lawrence; P A Watt; C Hillier; A C Burden; H Thurston
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

8.  Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.

Authors:  E K Maxfield; N E Cameron; M A Cotter; K C Dines
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

9.  Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert; J Giese; N J Christensen; L Bent-Hansen; M D Nielsen
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

10.  Mechanisms in rabbit aorta for hyperglycaemia-induced alterations in angiotensin II and norepinephrine effects.

Authors:  D A Simmons; A I Winegrad
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.